Literature DB >> 18028478

Cell lines of hyperdiploid myeloma, are we there yet?

Wee J Chng, Rafael Fonseca.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18028478      PMCID： PMC2629812          DOI： 10.1111/j.1365-2141.2007.06905.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients.

Authors:  Daniel R Carrasco; Giovanni Tonon; Yongsheng Huang; Yunyu Zhang; Raktim Sinha; Bin Feng; James P Stewart; Fenghuang Zhan; Deepak Khatry; Marina Protopopova; Alexei Protopopov; Kumar Sukhdeo; Ichiro Hanamura; Owen Stephens; Bart Barlogie; Kenneth C Anderson; Lynda Chin; John D Shaughnessy; Cameron Brennan; Ronald A Depinho
Journal:  Cancer Cell       Date:  2006-04       Impact factor: 31.743

2.  The molecular classification of multiple myeloma.

Authors:  Fenghuang Zhan; Yongsheng Huang; Simona Colla; James P Stewart; Ichiro Hanamura; Sushil Gupta; Joshua Epstein; Shmuel Yaccoby; Jeffrey Sawyer; Bart Burington; Elias Anaissie; Klaus Hollmig; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

3.  Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.

Authors:  S V Rajkumar; R Fonseca; G W Dewald; T M Therneau; M Q Lacy; R A Kyle; P R Greipp; M A Gertz
Journal:  Cancer Genet Cytogenet       Date:  1999-08

4.  Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.

Authors:  Wee J Chng; Shaji Kumar; Scott Vanwier; Greg Ahmann; Tammy Price-Troska; Kim Henderson; Tae-Hoon Chung; Seungchan Kim; George Mulligan; Barbara Bryant; John Carpten; Morie Gertz; S Vincent Rajkumar; Martha Lacy; Angela Dispenzieri; Robert Kyle; Philip Greipp; P Leif Bergsagel; Rafael Fonseca
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

5.  Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma.

Authors:  Wee J Chng; Rhett P Ketterling; Rafael Fonseca
Journal:  Genes Chromosomes Cancer       Date:  2006-12       Impact factor: 5.006

6.  Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines.

Authors:  Xin Li; Angela Pennisi; Fenghuang Zhan; Jeffrey R Sawyer; John D Shaughnessy; Shmuel Yaccoby
Journal:  Br J Haematol       Date:  2007-09       Impact factor: 6.998

7.  Genetics and cytogenetics of multiple myeloma: a workshop report.

Authors:  Rafael Fonseca; Bart Barlogie; Regis Bataille; Christian Bastard; P Leif Bergsagel; Marta Chesi; Faith E Davies; Johannes Drach; Philip R Greipp; Ilan R Kirsch; W Michael Kuehl; Jesus M Hernandez; Stephane Minvielle; Linda M Pilarski; John D Shaughnessy; A Keith Stewart; Herve Avet-Loiseau
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701
  7 in total
  1 in total

1.  OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus.

Authors:  Thea Kristin Våtsveen; Erming Tian; Stine H Kresse; Leonardo A Meza-Zepeda; Ana Gabrea; Oleg Glebov; Hong Yan Dai; Anders Sundan; W Michael Kuehl; Magne Børset
Journal:  Leuk Res       Date:  2009-04-23       Impact factor: 3.156
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.